Cardiac impairment in rabbits fed a high-fat diet is counteracted by dehydroepiandrosterone supplementation

Life Sciences

Volumn 85, Issue 1-2, 2009, Pages 77-84

  Aragno, M ^a   Meineri, G ^a   Vercellinatto, I ^a   Bardini, P ^a   Raimondo, S ^a   Peiretti, P G ^b   Vercelli, A ^c   Alloatti, G ^a   Tomasinelli, C E ^a   Danni, O ^a   Boccuzzi, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b NRC   (Italy)

^c Associated Veterinary Ambulatory   (Italy)

Author keywords

Cardiac impairment; Dehydroepiandrosterone; High fat diet; Myosin; Oxidative stress; Rabbits

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; MYOSIN HEAVY CHAIN; PRASTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADD ON THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GLYCATION; HEART INJURY; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE NECROSIS; HEART PAPILLARY MUSCLE; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID DIET; LIPID STORAGE; LOW DRUG DOSE; MALE; MUSCLE FUNCTION; NEW ZEALAND; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RABBIT;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CELL NUCLEUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSOL; DEHYDROEPIANDROSTERONE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIET; DIETARY FATS; GLUCOSE TOLERANCE TEST; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART DISEASES; HEART FUNCTION TESTS; HEART VENTRICLES; MALE; MASS SPECTROMETRY; MYOCARDIUM; MYOSINS; NECROSIS; OXIDATIVE STRESS; RABBITS; RNA;

ORYCTOLAGUS CUNICULUS;

EID: 67349230809     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.04.020     Document Type: Article

References (56)

1. Aebi H. Catalase in vitro. Methods in Enzymology 105 (1984) 121-126
2. Aragno M., Parola S., Brignardello E., Mauro A., Tamagno E., Manti R., Danni O., and Boccuzzi G. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes 49 (2000) 1924-1931
3. Aragno M., Mastrocola R., Catalano M.G., Brignardello E., Danni O., and Boccuzzi G. Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes 53 (2004) 1082-1088
4. Aragno M., Mastrocola R., Medana C., Restivo F., Catalano M.G., Pons N., Danni O., and Boccuzzi G. Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment. Endocrinology 146 (2005) 5561-5567
5. Aragno M., Mastrocola R., Medana C., Catalano M.G., Vercellinatto I., Danni O., and Boccuzzi G. Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology 147 (2006) 5967-5974
6. Aragno M., Mastrocola R., Alloatti G., Vercellinatto I., Bardini P., Geuna S., Catalano M.G., Danni O., and Boccuzzi G. Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 149 (2008) 380-388
7. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 72 (1976) 248-254
8. Brignardello E., Beltramo E., Molinatti P.A., Aragno M., Gatto V., Tamagno E., Danni O., Porta M., and Boccuzzi G. Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. Journal of Endocrinology 158 (1998) 21-26
9. Brignardello E., Gallo M., Aragno M., Manti R., Tamagno E., Danni O., and Boccuzzi G. Dehydroepiandrosterone prevents lipid peroxidation and cell growth inhibition induced by high glucose concentration in cultured rat mesangial cells. Journal of Endocrinology 166 (2000) 401-406
10. Brignardello E., Runzo C., Aragno M., Catalano M.G., Cassader M., Perin P.C., and Boccuzzi G. Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients. Diabetes Care 30 (2007) 2922-2927
11. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54 (2005) 1615-1625
12. Buettner R., Parhofer K.G., Woenckhaus M., Wrede C.E., Kunz-Schughart L.A., Scholmerich J., and Bollheimer L.C. Defining high fat diet rat models: Metabolic and molecular effects of different fat types. Journal of Molecular Endocrinology 36 (2006) 485-501
13. Callies F., Fassnacht M., van Vlijmen J.C., Koehler I., Huebler D., Seibel M.J., Arlt W., and Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency: Effects on body composition, serum leptin, bone turnover, and exercise capacity. Journal of Clinical Endocrinology and Metabolism 86 (2001) 1968-1972
14. Carroll J.F., and Tyagi S.C. Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit. American Journal of Hypertension 18 (2005) 692-698
15. Christiansen J.J., Gravhol C.H., Fisker S., Svenstrup B., Bennett P., Veldhuis J., Andersen M., Christiansen J.C., and Jørgensen J.O.L. Dehydroepiandrosterone supplementation in women with adrenal failure: Impact on twenty-four hour GH secretion and IGF-related parameters. Clinical Endocrinology 60 (2004) 461-469
16. Davì G., Ciabattoni G., Consoli A., Mezzetti A., Falco A., Santarone S., Pennese E., Vitacolonna E., Bucciarelli T., Costantini F., Capani F., and Patrono C. In vivo formation of 8-iso-prostaglandin-alpha and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation. Circulation 99 (1999) 224-229
17. Deng Q.G., She H., Cheng J.H., French S.W., Koop D.R., Xiong S., and Tsukamoto H. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 42 (2005) 905-914
18. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 11 (1991) 81-128
19. Farhangkhoee H., Khan Z.A., Kaur H., Xin X., Chen S., and Chakrabarti S. Vascular endothelial dysfunction in diabetic cardiomyopathy: Pathogenesis and potential treatment targets. Pharmacology and Therapeutics 111 (2005) 384-399
20. Flohé L., and Otting F. Superoxide dismutase assays. Methods Enzymology 105 (1984) 93-104
21. Gao J., Sun H.Y., Zhu Z.R., Ding Z., and Zhu L. Antioxidant effects of dehydroepiandrosterone are related to up-regulation of thioredoxin in SH-SY5Y cells. Acta Biochimica and Biophysica Sinica 37 (2005) 119-125
22. González-Vílchez F., Ayuela J., Ares M., Pi J., Castillo L., and Martín-Durán R. Oxidative stress and fibrosis in incipient myocardial dysfunction in type 2 diabetic patients. International Journal of Cardiology 101 (2005) 53-58
23. Gupta M., Sueblinvong V., Raman J., Jeevanandam V., and Gupta M.P. Single-stranded DNA-binding proteins PURalpha and PURbeta bind to a purine-rich negative regulatory element of the alpha-myosin heavy chain gene and control transcriptional and translational regulation of the gene expression. Implications in the repression of alpha-myosin heavy chain during heart failure. Journal of Biological Chemistry 278 (2003) 44935-44948
24. Han S.N., Leka L.S., Lichtenstein A.H., Ausman L.M., Schaefer E.J., and Meydani S.N. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. Journal of Lipid Research 43 (2002) 445-452
25. Hartog J.W., Voors A., Bakker S.J., Smit A.J., and van Veldhuisen D.J. Advanced glycation end-products (AGEs) and heart failure: Pathophysiology and clinical implications. European Journal of Heart Failure 9 (2007) 1146-1155
26. Hayashi T., Esaki T., Muto E., Kano H., Asai Y., Thakur N.K., Sumi D., Jayachandran M., and Iguchi A. Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: The possible role of nitric oxide. Arteriosclerosis, Thrombosis, and Vascular Biology 20 (2000) 782-792
27. Hunt P.J., Gurnell E.M., Huppert F.A., Richards C., Prevost A.T., Wass J.A., Herbert J., and Chatterjee V.K. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. Journal of Clinical Endocrinology and Metabolism 85 (2000) 4650-4656
28. Igwebuike A., Irving B.A., Bigelow M.L., Short K.R., McConnell J.P., and Nair K.S. Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 93 (2008) 534-536
29. 4. Nature 227 (1970) 680-685
30. Liu D., Si H., Reynolds K.A., Zhen W., Jia Z., and Dillon J.S. Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology 148 (2007) 3068-3076
31. Masoudi F.A., and Inzucchi S.E. Diabetes mellitus and heart failure: Epidemiology, mechanisms, and pharmacotherapy. American Journal of Cardiology 99 (2007) 113-132
32. Mauriège P., Martel C., Langin D., Lacaille M., Després J.P., Bélanger A., Labrie F., and Deshaies Y. Chronic effects of dehydroepiandrosterone on rat adipose tissue metabolism. Metabolism 52 (2003) 264-272
33. Meldrum D.R., Shenkar R., Sheridan B.C., Cain B.S., Abraham E., and Harken A.H. Hemorrhage activates myocardial NFkB and increases TNF-α in the heart. Journal of Molecular and Cellular Cardiology 29 (1997) 2849-2854
34. Minamiyama Y., Takemura S., Bito Y., Shinkawa H., Tsukioka T., Nakahira A., Suehiro S., and Okada S. Supplementation of alpha-tocopherol improves cardiovascular risk factors via the insulin signalling pathway and reduction of mitochondrial reactive oxygen species in type 2 diabetic rats. Free Radical Research 42 (2008) 261-271
35. Miyata T., van Ypersele de Strihou C., Imasawa T., Yoshino A., Ueda Y., Ogura H., Kominami K., Onogi H., Inagi R., Nangaku M., and Kurokawa K. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient. Kidney International 60 (2001) 2351-2359
36. Moriyama Y., Yasue H., Yoshimura M., Mizuno Y., Nishiyama K., Tsunoda R., Kawano H., Kugiyama K., Ogawa H., Saito Y., and Nakao K. The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity. Journal of Clinical Endocrinology and Metabolism 85 (2000) 1834-1840
37. Nakamura S., Yoshimura M., Nakayama M., Ito T., Mizuno Y., Harada E., Sakamoto T., Saito Y., Nakao K., Yasue H., and Ogawa H. Possible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in human heart. Circulation 110 (2004) 1787-1793
38. Owens C.W.I., and Belcher R.V. A colorimetric micro-method for the determination of glutathione. Biochemical Journal 94 (1965) 705-709
39. Pérez-de-Heredia F., Sánchez J., Priego T., Nicolás F., Portillo Mdel P., Palou A., Zamora S., and Garaulet M. Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats. Steroids 73 (2008) 1128-1136
40. Perusquía M., Navarrete E., González L., and Villalón C.M. The modulatory role of androgens and progestins in the induction of vasorelaxation in human umbilical artery. Life Sciences 81 (2007) 993-1002
41. Ramamurthy B., Höök P., Jones A.D., and Larsson L. Changes in myosin structure and function in response to glycation. FASEB Journal 15 (2001) 2415-2422
42. Razeghi P., Young M.E., Cockrill T.C., Frazier O.H., and Taegtmeyer H. Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure. Circulation 106 (2002) 407-411
43. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine 347 (2002) 1557-1565
44. Robertson R.P. Oxidative stress and impaired insulin secretion in type 2 diabetes. Current Opinion in Pharmacology 6 (2006) 615-619
45. Russell J.C., and Proctor S.D. Small animal models of cardiovascular disease: Tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. Cardiovascular Pathology 15 (2006) 318-330
46. Shepherd A., and Cleary M.P. Metabolic alterations after dehydroepiandrosterone treatment in Zucker rats. American Journal of Physiology 246 (1984) 123-128
47. Simoncini T., and Genazzani A.R. Dehydroepiandrosterone, the endothelium, and cardiovascular protection. Endocrinology 148 (2007) 3065-3067
48. Smith H.M., Hamblin M., and Hill M.F. Greater propensity of diabetic myocardium for oxidative stress after myocardial infarction is associated with the development of heart failure. Journal of Molecular and Cellular Cardiology 39 (2005) 657-665
49. Tang X., Ma H., Zou S., and Chen W. Effects of dehydroepiandrosterone (DHEA) on hepatic lipid metabolism parameters and lipogenic gene mRNA expression in broiler chickens. Lipids 42 (2007) 1025-1033
50. Tchernof A., and Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: A review of human studies. European Journal of Endocrinology 151 (2004) 1-14
51. Wang Y., Guo X., and Dhalla N.S. Modification of myosin protein and gene expression in failling hearts due to myocardial infarction by enalapril or losartan. Biochimica et Biophysica Acta 1690 (2004) 177-184
52. Wang Y., Ausman L.M., Russel R.M., Greenberg A.S., and Wang X.D. Increased apoptosis in high-fat diet induced non-alcoholic steatohepatitis in rats is associated with c-jun NH2 terminal kinase activation and elevated proapoptotic bax. Journal of Nutrition 138 (2008) 1866-1871
53. Wold L.E., Ceylan-Isik A.F., and Ren J. Oxidative stress and stress signaling: Menace of diabetic cardiomyopathy. Acta Pharmacologica Sinica 26 (2005) 908-917
54. Yildirim A., Gumus M., Dalga S., Sahin Y.N., and Akcay F. Dehydroepiandrosterone improves hepatic antioxidant systems after renal ischemia-reperfusion injury in rabbits. Annals of Clinical and Laboratory Science 33 (2003) 459-464
55. Zylinska L., Kowalska I., and Ferenc B. Calmodulin effects on steroids-regulated plasma membrane calcium pump activity. Cell Biochemistry and Function 27 (2009) 111-117
56. Zoccorato F., Deana R., Cavallini L., and Alexandre A. Generation of hydrogen peroxide by cerebral cortex synaptosomes. European Journal of Biochemistry 180 (1989) 473-478